MELEXIS NV (MELE.BR) Fundamental Analysis & Valuation

EBR:MELE • BE0165385973

Current stock price

63.275 EUR
+2.48 (+4.07%)
Last:

This MELE.BR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. MELE.BR Profitability Analysis

1.1 Basic Checks

  • In the past year MELE was profitable.
  • In the past year MELE had a positive cash flow from operations.
  • MELE had positive earnings in each of the past 5 years.
  • Each year in the past 5 years MELE had a positive operating cash flow.
MELE.BR Yearly Net Income VS EBIT VS OCF VS FCFMELE.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M

1.2 Ratios

  • The Return On Assets of MELE (12.46%) is better than 70.42% of its industry peers.
  • The Return On Equity of MELE (23.22%) is better than 71.83% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 13.97%, MELE is in the better half of the industry, outperforming 69.01% of the companies in the same industry.
Industry RankSector Rank
ROA 12.46%
ROE 23.22%
ROIC 13.97%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MELE.BR Yearly ROA, ROE, ROICMELE.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

1.3 Margins

  • With a Profit Margin value of 13.40%, MELE perfoms like the industry average, outperforming 52.11% of the companies in the same industry.
  • In the last couple of years the Profit Margin of MELE has remained more or less at the same level.
  • MELE has a Operating Margin (15.96%) which is in line with its industry peers.
  • In the last couple of years the Operating Margin of MELE has remained more or less at the same level.
  • Looking at the Gross Margin, with a value of 38.59%, MELE is doing worse than 76.06% of the companies in the same industry.
  • In the last couple of years the Gross Margin of MELE has remained more or less at the same level.
Industry RankSector Rank
OM 15.96%
PM (TTM) 13.4%
GM 38.59%
OM growth 3Y-16.81%
OM growth 5Y1.3%
PM growth 3Y-17.17%
PM growth 5Y-0.38%
GM growth 3Y-3.44%
GM growth 5Y1.26%
MELE.BR Yearly Profit, Operating, Gross MarginsMELE.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

6

2. MELE.BR Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), MELE is creating some value.
  • MELE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
MELE.BR Yearly Shares OutstandingMELE.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
MELE.BR Yearly Total Debt VS Total AssetsMELE.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • MELE has an Altman-Z score of 6.40. This indicates that MELE is financially healthy and has little risk of bankruptcy at the moment.
  • With a Altman-Z score value of 6.40, MELE perfoms like the industry average, outperforming 56.34% of the companies in the same industry.
  • MELE has a debt to FCF ratio of 3.32. This is a good value and a sign of high solvency as MELE would need 3.32 years to pay back of all of its debts.
  • With a Debt to FCF ratio value of 3.32, MELE perfoms like the industry average, outperforming 46.48% of the companies in the same industry.
  • MELE has a Debt/Equity ratio of 0.63. This is a neutral value indicating MELE is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.63, MELE is not doing good in the industry: 80.28% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 3.32
Altman-Z 6.4
ROIC/WACC1.18
WACC11.89%
MELE.BR Yearly LT Debt VS Equity VS FCFMELE.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M

2.3 Liquidity

  • MELE has a Current Ratio of 5.46. This indicates that MELE is financially healthy and has no problem in meeting its short term obligations.
  • MELE's Current ratio of 5.46 is amongst the best of the industry. MELE outperforms 88.73% of its industry peers.
  • MELE has a Quick Ratio of 2.63. This indicates that MELE is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of MELE (2.63) is better than 80.28% of its industry peers.
Industry RankSector Rank
Current Ratio 5.46
Quick Ratio 2.63
MELE.BR Yearly Current Assets VS Current LiabilitesMELE.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

4

3. MELE.BR Growth Analysis

3.1 Past

  • MELE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -34.04%.
  • The Earnings Per Share has been growing by 10.29% on average over the past years. This is quite good.
  • MELE shows a decrease in Revenue. In the last year, the revenue decreased by -9.99%.
  • The Revenue has been growing by 10.59% on average over the past years. This is quite good.
EPS 1Y (TTM)-34.04%
EPS 3Y-17%
EPS 5Y10.29%
EPS Q2Q%24.44%
Revenue 1Y (TTM)-9.99%
Revenue growth 3Y0.14%
Revenue growth 5Y10.59%
Sales Q2Q%8.66%

3.2 Future

  • Based on estimates for the next years, MELE will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.02% on average per year.
  • MELE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.71% yearly.
EPS Next Y8%
EPS Next 2Y17.16%
EPS Next 3Y17.33%
EPS Next 5Y14.02%
Revenue Next Year0.9%
Revenue Next 2Y4.94%
Revenue Next 3Y6.08%
Revenue Next 5Y6.71%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MELE.BR Yearly Revenue VS EstimatesMELE.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 500M 1B 1.5B
MELE.BR Yearly EPS VS EstimatesMELE.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8

5

4. MELE.BR Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 22.68, MELE is valued on the expensive side.
  • MELE's Price/Earnings ratio is rather cheap when compared to the industry. MELE is cheaper than 80.28% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 27.53. MELE is around the same levels.
  • MELE is valuated rather expensively with a Price/Forward Earnings ratio of 21.00.
  • Based on the Price/Forward Earnings ratio, MELE is valued a bit cheaper than the industry average as 78.87% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 37.95, MELE is valued a bit cheaper.
Industry RankSector Rank
PE 22.68
Fwd PE 21
MELE.BR Price Earnings VS Forward Price EarningsMELE.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, MELE is valued a bit cheaper than 74.65% of the companies in the same industry.
  • MELE's Price/Free Cash Flow ratio is rather cheap when compared to the industry. MELE is cheaper than 80.28% of the companies in the same industry.
Industry RankSector Rank
P/FCF 26.37
EV/EBITDA 14.65
MELE.BR Per share dataMELE.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates MELE does not grow enough to justify the current Price/Earnings ratio.
  • MELE's earnings are expected to grow with 17.33% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.84
PEG (5Y)2.2
EPS Next 2Y17.16%
EPS Next 3Y17.33%

7

5. MELE.BR Dividend Analysis

5.1 Amount

  • MELE has a Yearly Dividend Yield of 4.68%, which is a nice return.
  • MELE's Dividend Yield is rather good when compared to the industry average which is at 0.65. MELE pays more dividend than 98.59% of the companies in the same industry.
  • MELE's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 4.68%

5.2 History

  • The dividend of MELE is nicely growing with an annual growth rate of 10.98%!
Dividend Growth(5Y)10.98%
Div Incr Years0
Div Non Decr Years7
MELE.BR Yearly Dividends per shareMELE.BR Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

5.3 Sustainability

  • 131.42% of the earnings are spent on dividend by MELE. This is not a sustainable payout ratio.
  • The dividend of MELE is growing, but earnings are growing more, so the dividend growth is sustainable.
DP131.42%
EPS Next 2Y17.16%
EPS Next 3Y17.33%
MELE.BR Yearly Income VS Free CF VS DividendMELE.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M
MELE.BR Dividend Payout.MELE.BR Dividend Payout, showing the Payout Ratio.MELE.BR Dividend Payout.PayoutRetained Earnings

MELE.BR Fundamentals: All Metrics, Ratios and Statistics

MELEXIS NV

EBR:MELE (4/17/2026, 4:22:46 PM)

63.275

+2.48 (+4.07%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)02-04
Earnings (Next)04-29
Inst Owners17.67%
Inst Owner ChangeN/A
Ins Owners25%
Ins Owner ChangeN/A
Market Cap2.56B
Revenue(TTM)839.62M
Net Income(TTM)112.51M
Analysts76
Price Target63.91 (1%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.68%
Yearly Dividend3.7
Dividend Growth(5Y)10.98%
DP131.42%
Div Incr Years0
Div Non Decr Years7
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-13.76%
Min EPS beat(2)-20.2%
Max EPS beat(2)-7.32%
EPS beat(4)1
Avg EPS beat(4)3.1%
Min EPS beat(4)-20.2%
Max EPS beat(4)42.38%
EPS beat(8)2
Avg EPS beat(8)-3.06%
EPS beat(12)5
Avg EPS beat(12)-2.06%
EPS beat(16)8
Avg EPS beat(16)0.6%
Revenue beat(2)0
Avg Revenue beat(2)-2.39%
Min Revenue beat(2)-2.86%
Max Revenue beat(2)-1.91%
Revenue beat(4)1
Avg Revenue beat(4)-0.84%
Min Revenue beat(4)-2.86%
Max Revenue beat(4)3.28%
Revenue beat(8)1
Avg Revenue beat(8)-1.88%
Revenue beat(12)2
Avg Revenue beat(12)-1.62%
Revenue beat(16)5
Avg Revenue beat(16)-1.08%
PT rev (1m)-0.61%
PT rev (3m)-11.47%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.24%
EPS NY rev (1m)-1.16%
EPS NY rev (3m)-15.22%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.93%
Revenue NY rev (1m)-0.62%
Revenue NY rev (3m)-7.32%
Valuation
Industry RankSector Rank
PE 22.68
Fwd PE 21
P/S 3.04
P/FCF 26.37
P/OCF 20.24
P/B 5.28
P/tB 5.29
EV/EBITDA 14.65
EPS(TTM)2.79
EY4.41%
EPS(NY)3.01
Fwd EY4.76%
FCF(TTM)2.4
FCFY3.79%
OCF(TTM)3.13
OCFY4.94%
SpS20.78
BVpS11.99
TBVpS11.96
PEG (NY)2.84
PEG (5Y)2.2
Graham Number27.4386 (-56.64%)
Profitability
Industry RankSector Rank
ROA 12.46%
ROE 23.22%
ROCE 16.8%
ROIC 13.97%
ROICexc 14.61%
ROICexgc 14.63%
OM 15.96%
PM (TTM) 13.4%
GM 38.59%
FCFM 11.55%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-16.81%
OM growth 5Y1.3%
PM growth 3Y-17.17%
PM growth 5Y-0.38%
GM growth 3Y-3.44%
GM growth 5Y1.26%
F-Score5
Asset Turnover0.93
Health
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 3.32
Debt/EBITDA 1.64
Cap/Depr 55.05%
Cap/Sales 3.5%
Interest Coverage 14.46
Cash Conversion 67.44%
Profit Quality 86.17%
Current Ratio 5.46
Quick Ratio 2.63
Altman-Z 6.4
F-Score5
WACC11.89%
ROIC/WACC1.18
Cap/Depr(3y)125.38%
Cap/Depr(5y)110.34%
Cap/Sales(3y)6.34%
Cap/Sales(5y)5.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-34.04%
EPS 3Y-17%
EPS 5Y10.29%
EPS Q2Q%24.44%
EPS Next Y8%
EPS Next 2Y17.16%
EPS Next 3Y17.33%
EPS Next 5Y14.02%
Revenue 1Y (TTM)-9.99%
Revenue growth 3Y0.14%
Revenue growth 5Y10.59%
Sales Q2Q%8.66%
Revenue Next Year0.9%
Revenue Next 2Y4.94%
Revenue Next 3Y6.08%
Revenue Next 5Y6.71%
EBIT growth 1Y-39.08%
EBIT growth 3Y-16.7%
EBIT growth 5Y12.03%
EBIT Next Year45.42%
EBIT Next 3Y25.78%
EBIT Next 5Y18.48%
FCF growth 1Y-22.5%
FCF growth 3Y-13.14%
FCF growth 5Y6.45%
OCF growth 1Y-29.12%
OCF growth 3Y-12.39%
OCF growth 5Y5.69%

MELEXIS NV / MELE.BR Fundamental Analysis FAQ

What is the ChartMill fundamental rating of MELEXIS NV (MELE.BR) stock?

ChartMill assigns a fundamental rating of 5 / 10 to MELE.BR.


What is the valuation status of MELEXIS NV (MELE.BR) stock?

ChartMill assigns a valuation rating of 5 / 10 to MELEXIS NV (MELE.BR). This can be considered as Fairly Valued.


Can you provide the profitability details for MELEXIS NV?

MELEXIS NV (MELE.BR) has a profitability rating of 5 / 10.


What are the PE and PB ratios of MELEXIS NV (MELE.BR) stock?

The Price/Earnings (PE) ratio for MELEXIS NV (MELE.BR) is 22.68 and the Price/Book (PB) ratio is 5.28.


Is the dividend of MELEXIS NV sustainable?

The dividend rating of MELEXIS NV (MELE.BR) is 7 / 10 and the dividend payout ratio is 131.42%.